Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 285

1.

Delayed liver laceration following transjugular intrahepatic portosystemic shunt for portal hypertension.

Liu K, Fan XX, Wang XL, He CS, Wu XJ.

World J Gastroenterol. 2012 Dec 28;18(48):7405-8. doi: 10.3748/wjg.v18.i48.7405.

2.

Reducing risk of transjugular intrahepatic portosystemic shunt using ultrasound guided single needle pass.

Leong S, Kok HK, Govender P, Torreggiani W.

World J Gastroenterol. 2013 Jun 14;19(22):3528-30. doi: 10.3748/wjg.v19.i22.3528.

3.

A patient with portal hypertension and blindness after transjugular intrahepatic portosystemic shunt.

Appenrodt B, Schepke M, Kuntz-Hehner S, Schmiedel A, Sauerbruch T.

Eur J Gastroenterol Hepatol. 2006 Apr;18(4):447-9.

PMID:
16538120
4.

[Hemolytic anemia secondary to the placement of a portosystemic stented shunt].

Carrillo-Esper R, Carrillo-Cortes U, Carrillo-Córdova JR, Carrillo-Córdova LD, Carrillo-Córdova CA, Carrillo-Córdova DM.

Cir Cir. 2013 Mar-Apr;81(2):143-7. Spanish.

PMID:
23522316
5.

The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.

Colombato L.

J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S344-51. Review.

PMID:
17975487
6.

Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.

Siramolpiwat S.

World J Gastroenterol. 2014 Dec 7;20(45):16996-7010. doi: 10.3748/wjg.v20.i45.16996. Review.

7.

[Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of complications of portal hypertension in patients with liver cirrhosis].

Grønbaek H, Astrup LB, Nielsen DT, Vilstrup H.

Ugeskr Laeger. 2003 Jan 27;165(5):439-42. Review. Danish.

PMID:
12599838
8.

Reduction in portal venous pressure by transjugular intrahepatic portosystemic shunt for treatment of hemorrhagic stomal varices.

Deipolyi AR, Kalva SP, Oklu R, Walker TG, Wicky S, Ganguli S.

AJR Am J Roentgenol. 2014 Sep;203(3):668-73. doi: 10.2214/AJR.13.12211.

PMID:
25148174
9.

CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.

Berres ML, Asmacher S, Lehmann J, Jansen C, Görtzen J, Klein S, Meyer C, Strunk HM, Fimmers R, Tacke F, Strassburg CP, Trautwein C, Sauerbruch T, Wasmuth HE, Trebicka J.

J Hepatol. 2015 Feb;62(2):332-9. doi: 10.1016/j.jhep.2014.09.032. Epub 2014 Oct 17.

PMID:
25457205
10.

Recanalization of an occluded intrahepatic portosystemic covered stent via the percutaneous transhepatic approach.

Chan CY, Liang PC.

Korean J Radiol. 2010 Jul-Aug;11(4):469-71. doi: 10.3348/kjr.2010.11.4.469. Epub 2010 Jun 21.

11.

Parallel transjugular intrahepatic portosystemic shunt for controlling portal hypertension complications in cirrhotic patients.

He FL, Wang L, Yue ZD, Zhao HW, Liu FQ.

World J Gastroenterol. 2014 Sep 7;20(33):11835-9. doi: 10.3748/wjg.v20.i33.11835.

12.

Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.

Qiu B, Zhao MF, Yue ZD, Zhao HW, Wang L, Fan ZH, He FL, Dai S, Yao JN, Liu FQ.

World J Gastroenterol. 2015 Nov 21;21(43):12439-47. doi: 10.3748/wjg.v21.i43.12439.

13.

Clinical effects and complications of TIPS for portal hypertension due to cirrhosis: a single center.

Qin JP, Jiang MD, Tang W, Wu XL, Yao X, Zeng WZ, Xu H, He QW, Gu M.

World J Gastroenterol. 2013 Nov 28;19(44):8085-92. doi: 10.3748/wjg.v19.i44.8085.

14.

The management of the cirrhotic patient after transjugular intrahepatic portosystemic shunt.

Sanyal AJ.

Semin Gastrointest Dis. 1997 Oct;8(4):188-99. Review.

PMID:
9360283
15.

Transjugular intrahepatic portosystemic shunt (TIPS); review of initial experience at Aga Khan University Hospital.

Hamid RS, Tanveer-ul-haq, Azeemuddin M, Sajjad Z, Chishti I, Salam B.

J Pak Med Assoc. 2011 Apr;61(4):336-9.

16.

Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.

Parker R.

Clin Liver Dis. 2014 May;18(2):319-34. doi: 10.1016/j.cld.2013.12.004. Review.

PMID:
24679497
17.

The role of transjugular intrahepatic portosystemic shunt prior to abdominal tumoral surgery in cirrhotic patients with portal hypertension.

Gil A, Martínez-Regueira F, Hernández-Lizoain JL, Pardo F, Olea JM, Bastarrika G, Cienfuegos JA, Bilbao JI.

Eur J Surg Oncol. 2004 Feb;30(1):46-52.

PMID:
14736522
18.

Transjugular intrahepatic portosystemic shunts (TIPS).

Kamath PS, McKusick MA.

Baillieres Clin Gastroenterol. 1997 Jun;11(2):327-49. Review.

PMID:
9395751
19.
20.

Transjugular intrahepatic portosystemic shunt in five children with cystic fibrosis: long-term results.

Pozler O, Krajina A, Vanicek H, Hulek P, Zizka J, Michl A, Elias P.

Hepatogastroenterology. 2003 Jul-Aug;50(52):1111-4.

PMID:
12845992

Supplemental Content

Support Center